Sabra Healthcare REIT Inc (NASDAQ:SBRA) finished Friday with a subtraction of -$0.06 to close at $13.94, a downside of -0.43 percent. An average of 2,450,240 shares of common stock have been traded in the last five days. The last 20 days have seen an average of 3,040,500 shares traded, while the 50-day average volume stands at 2,446,038.
SBRA stock has increased by 9.42% in the last month. The company shares reached their 1-month lowest point of $12.31 on 08/30/23. With the stock rallying to its 52-week high on 09/22/23, shares of the company touched a low of $10.08 and a high of $14.32 in 52 weeks. It has reached a new high 13 times so far this year and achieved 12.15% or $1.51 in price. In spite of this, the price is down -2.65% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Sabra Healthcare REIT Inc (SBRA) stock’s beta is 1.24. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 5.12, the price-to-book (PB) ratio at 1.09, and the price-to-cash flow ratio at 10.23.
Financial Health
Further, the company has a long term debt to equity ratio of 0.83 and a total debt to equity ratio of 0.84 for the quarter ending June 29. Its gross profit as reported stood at $140.66 million compared to revenue of $624.81 million.
Earnings Surprise
For the three-month period that ended June 29, Sabra Healthcare REIT Inc had $48.27 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $21.19 million in the quarter, while revenues of -$9.49 million were grew 20.67%. The analyst consensus anticipated Sabra Healthcare REIT Inc’s latest quarter earnings to come in at $0.1 per share, but it turned out to be $0.09, a -10.00% surprise. For the quarter, EBITDA amounted to $102.47 million. At the end of the quarter ending June 29, Sabra Healthcare REIT Inc’s stock balance sheet showed total debt was $2.42 billion. Shareholders own equity worth $231.22 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Sabra Healthcare REIT Inc (SBRA) price momentum. RSI 9-day as of the close on 29 September was 67.27%, suggesting the stock is Neutral, with historical volatility in this time frame at 25.17%.
As of today, SBRA’s price is $13.90 unch or $unch from its 5-day moving average. SBRA is currently trading +11.25% higher than its 20-day SMA and +22.82% higher than its 100-day SMA. However, the stock’s current price level is +6.33% above the SMA50 and +10.81% above the SMA200.
The stochastic %K and %D were 68.23% and 69.67%, respectively, and the average true range (ATR) was 0.32. With the 14-day stochastic at 67.80% and the average true range at 0.31, the RSI (14) stands at 66.60%. The stock has reached 0.05 on the 9-day MACD Oscillator while the 14-day reading was at 0.24.
Analyst Ratings
Jefferies upgraded Sabra Healthcare REIT Inc (NASDAQ: SBRA) to a a Buy rating in its most recent analyst report. Previously, the stock was rated as a Hold. The consensus rating for Sabra Healthcare REIT Inc (SBRA) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell SBRA, while 9 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is SBRA’s price target for the next 12 months?
Analysts predict a range of price targets between $12.50 and $15.00, with a median target of $14.00. Taking a look at these predictions, the average price target given by analysts for Sabra Healthcare REIT Inc (SBRA) stock is $13.79.
